Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sterility Testing for Hematopoietic Stem Cells

27 Feb 2023

Abstract excerpt

Over the last two decades, rapid technological advances have led to the wide adoption of cell and gene therapy products for the treatment of a variety of disease states. In this study, we reviewed the literature between 2003 and 2021 to provide a summary of overarching trends associated with microbial contamination in hematopoietic stem cells (HSCs) derived from peripheral blood, bone marrow, and cord blood. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Hematopoietic Stem Cell Transplantation
Share to Neutropenia and Cancer Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36847535
DOI: 10.1128/jcm.01654-22

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sterility Testing for Hematopoietic Stem CellsPMID 36847535Read ↗

Gene therapy with hematopoietic stem and progenitor cell for monogenic disorders: a systematic review and meta-analysisSemantic proximity Read ↗

ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventionsSemantic proximity Read ↗

Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical productsSemantic proximity Read ↗

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.Semantic proximity Read ↗

Biosafety and Bioefficacy Assessment of Human Mesenchymal Stem Cells: What do we Know so Far?Semantic proximity Read ↗

Development of Cell and Gene Therapies for Clinical Use in the US and EU: Summary of Regulatory GuidelinesSemantic proximity Read ↗

Genetic Engineering and Manufacturing of Hematopoietic Stem CellsSemantic proximity Read ↗

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical ApplicationSemantic proximity Read ↗

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damageSemantic proximity Read ↗

Generation of KCL034 clinical grade human embryonic stem cell line.Semantic proximity Read ↗

GMP-compatible manufacturing of three iPS cell lines from human peripheral bloodSemantic proximity Read ↗

From Skin Biopsy to Neurons Through a Pluripotent Intermediate Under Good Manufacturing Practice ProtocolsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.